Doctor profile · Federal record
Dr. Molly Magnano, MD
Rheumatology Physician (CMS: Rheumatology) · Berkeley, CA
- NPI 1992743579
- Accepts Medicare
- MIPS 70.8 / 100 · 2023
- 25 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2850 Telegraph Ave, 120
Berkeley, CA 947051192
(510) 204-8120
fax (510) 649-1238
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #A80346
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992743579. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
41,653
Distinct HCPCS
10
Medicare allowed
$428,495
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 29,000 | 13 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,551 | 17 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 403 | 189 | $147 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 277 | 30 | $1 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 166 | 33 | $84 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 86 | 15 | $96 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 85 | 66 | $105 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 40 | 40 | $194 | |
20610 |
Aspiration and/or injection of fluid from large joint | 23 | 16 | $86 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 22 | 22 | $255 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,662. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$5,870
Transactions
151
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 39 | $3,031.39 | |
| Amgen Inc. | 27 | $552.22 | |
| Novartis Pharmaceuticals Corporation | 27 | $527.63 | |
| ABBVIE INC. | 16 | $513.36 | |
| UCB, Inc. | 7 | $212.85 | |
| AstraZeneca Pharmaceuticals LP | 6 | $173.87 | |
| Fresenius Kabi USA, LLC | 6 | $161.89 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $120.22 | |
| PFIZER INC. | 4 | $108.26 | |
| Aurinia Pharma U.S., Inc. | 3 | $80.55 | |
| Organon Llc | 3 | $65.51 | |
| Sandoz Inc. | 2 | $57.03 | |
| SOBI, INC | 2 | $56.76 | |
| Genentech USA, Inc. | 2 | $56.29 | |
| GENZYME CORPORATION | 2 | $52.06 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,155
Patients
293
Total drug cost
$1,242,550
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 211 | 65 | $2,227 |
| Methotrexate (Methotrexate Sodium) | Brand | 207 | 62 | $9,148 |
| Hydroxychloroquine Sulfate | Generic | 194 | 63 | $18,260 |
| Rinvoq (Upadacitinib) | Brand | 88 | 0 | $549,936 |
| Allopurinol | Generic | 79 | 19 | $1,110 |
| Meloxicam | Generic | 72 | 30 | $591 |
| Enbrel Sureclick (Etanercept) | Brand | 47 | 0 | $350,912 |
| Colchicine | Generic | 46 | 18 | $7,944 |
| Celecoxib | Generic | 44 | 13 | $2,558 |
| Folic Acid | Generic | 35 | 11 | $163 |
Hospital affiliations
Frequently asked questions
What is Dr. Molly Magnano's medical specialty?
Dr. Molly Magnano practices Rheumatology Physician in Berkeley, CA.
Where does Dr. Molly Magnano practice?
Dr. Molly Magnano practices at 2850 Telegraph Ave, Berkeley, CA 947051192. Office phone: 5102048120.
What is Dr. Molly Magnano's NPI?
Dr. Molly Magnano's National Provider Identifier (NPI) is 1992743579, issued by NPPES.
Does Dr. Molly Magnano accept Medicare assignment?
Yes. Dr. Molly Magnano accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Molly Magnano commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.